Global Antimicrobial Susceptibility Testing Market, By Product Type (Instruments, Consumables & Accessories, and Services & Software), Methods (Mass Spectrometry Method, Dilution, Disk Diffusion, E-Test, Genotypic Methods & Others), Type (Antibacterial Testing, Antifungal Testing & Rapid-AST), Application (Clinical Diagnostics, Drug Discovery and Development, Epidemiology & Others), End User (Hospitals, Pharmaceuticals and Biotechnology Companies, Diagnostic Laboratories, Contract Research Organizations, Research Centres and Academic Institutes & Others), Distribution Channel (Direct Sales, Retail Sales & Third Party Distributor), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Rest of South America, South Africa, and Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Market Analysis and Insights: Global Antimicrobial Susceptibility Testing Market
Antimicrobial susceptibility testing market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.9% in the forecast period of 2022 to 2029 and is expected to reach USD 5,688.50 million by 2029 from USD 3,616.78 million in 2021. The high prevalence of infectious diseases and increasing awareness towards early diagnosis is the major driver which is propelling the market in the forecast period.
Antimicrobial susceptibility testing (AST) is a laboratory procedure which is used to determine which antimicrobial impedes the growth of bacteria, fungi, and other microorganism causing a specific infection. Susceptibility testing is performed on microorganisms such as bacteria, fungi causing the infection after they have been recovered in a culture of the specimen.
Antibacterial drugs are playing the important role in the prevention of infectious diseases, however, the cases of drug misuse and overuse, led to the development of drug resistance. Delay in diagnosing the harmful microbes makes it difficult to control the spread of infectious diseases. This is putting pressure on the key players to manufacture the test kits which gives accurate and effective results to better treat the patients.
Testing is used to determine the potential effectiveness of antibiotics on microorganisms and determine if the microorganisms have developed resistance to certain antibiotics. The results of this test can help healthcare professionals to get access to better clinical diagnosis and select the drug that is most likely to be effective in treating that particular infection.
The global antimicrobial susceptibility testing market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Antimicrobial Susceptibility Testing Market Scope and Market Size
Global antimicrobial susceptibility testing market is categorized into six notable segments which are based on product type, methods, type, application, end user and distribution channel.
- On the basis of product type, antimicrobial susceptibility testing market is segmented into instruments, consumables & accessories and services & software. In 2022, instruments segment is expected to dominate the market as most companies are launching instruments for antimicrobial susceptibility testing.
- On the basis of methods, antimicrobial susceptibility testing market is segmented into mass spectrometry method, dilution, disk diffusion, e-test, genotypic methods, and others. In 2022, disk diffusion method is expected to dominate as this method provides the accurate, reliable, and efficient results.
- On the basis of type, antimicrobial susceptibility testing market is segmented into antibacterial testing, antifungal testing and others. In 2022, antibacterial testing segment is expected to dominate the market due to wide number of tests for antibacterial testing available in the market.
- On the basis of application, antimicrobial susceptibility testing market is segmented into clinical diagnostics, drug discovery and development, epidemiology and others. In 2022, clinical diagnostics segment is expected to dominate the market because these tests are most frequently done for clinical diagnosis.
- On the basis of end user, antimicrobial susceptibility testing market is segmented into hospitals, pharmaceuticals and biotechnology companies, diagnostic laboratories, contract research organizations, research centres & academic institutes and others. In 2022, hospitals segment is expected to dominate market because these antimicrobial tests are performed in hospitals to a great extent with latest technologies available.
- On the basis of distribution channel, antimicrobial susceptibility testing market is segmented into direct sales, retail sales and third party distributor. In 2022, direct sales segment is expected to dominate the market because consumers are aware of this distribution channel and they prefer direct sales for seeking the benefits of discounts, bulk buying and easy availability of products.
Antimicrobial Susceptibility Testing Market Country Level Analysis
The antimicrobial susceptibility testing market is analysed and market size information is provided by country, product type, methods, type, application, end user, distribution channel.
The countries covered in the antimicrobial susceptibility testing market report are the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey and rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and rest of Asia-Pacific, Brazil and rest of South America, South Africa and rest of Middle East and Africa.
North America is expected to dominate the market due to the rising investments in development of novel methods for testing. U.S is dominating in North America market due rise in epidemic and pandemic events and presence of sophisticated healthcare infrastructure. Europe is expected to grow with the third highest growth rate in the forecast period of 2022 to 2029 due to increasing demand of fitness and health tracking devices in the region. Germany is dominating the European market due to the rise in epidemic and pandemic events. The Asia-Pacific region is expected to grow with the most promising growth rate in the forecast period of 2022 to 2029 because of major companies foraying into the market such as Thermo Fisher Scientific Inc. and Bio-Rad Laboratories Inc. that are investing in developing testing methods that favor results with high accuracy and minimum turnaround time. South America is expected to dominate the market due to the rising investments in development of novel methods for testing. Brazil is dominating in South America market due rise in epidemic and pandemic events and presence of sophisticated healthcare infrastructure. South Africa is dominating the Middle East and Africa market with the increasing funding for the development of novel and innovative methods for testing.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Increasing Partnership and New Product Launch in Antimicrobial Susceptibility Testing Market is Creating New Opportunities for Players in the Antimicrobial Susceptibility Testing Market
The antimicrobial susceptibility testing market also provides you with detailed market analysis for every country growth in particular industry with wearable electronic devices sales, impact of advancement in the antimicrobial susceptibility testing and changes in regulatory scenarios with their support for the wearable electronic devices market. The data is available for historic period 2012 to 2020.
Competitive Landscape and Antimicrobial Susceptibility Testing Market Share Analysis
Antimicrobial susceptibility testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to antimicrobial susceptibility testing market.
The major companies which are dealing in the antimicrobial susceptibility testing market are BD, Synbiosis, Zhuhai DL Biotech Co., Ltd, Mast Group Ltd., HiMedia Laboratories, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Creative Diagnostics, Genefluidics, Inc., Rosco Diagnostica A/S, ERBA Group, Liofilchem S.r.l., Alifax S.r.l., MERLIN Gesellschaft für mikrobiologische Diagnostika mbH, bioMérieux SA, Merck KGaA, Danaher, Accelerate Diagnostics, Inc., NuMedii, Inc., and BacterioScan, Inc. among others.among other domestic and Asia-Pacific players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separatelyMany product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the antimicrobial susceptibility testing market.
For instance,
- In July 2020, Cepheid, a subsidiary of Danaher launched a novel rapid molecular test for TB which can detect multi-drug resistance to first-line and second-line drugs simultaneously. The profiling can be achieved in less than 90 minutes. This will drive the antimicrobial testing market in the coming years.
Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the wearable electronic devices market which also provides the benefit for organisation to improve their offering for antimicrobial susceptibility testing.
SKU-